Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

For Innovators and Researchers

Diagnostics and Therapeutics

The FDA has created a special emergency program for possible coronavirus therapies, the Coronavirus Treatment Acceleration Program (CTAP). The program uses every available method to move new treatments to patients as quickly as possible, while at the same time finding out whether they are helpful or harmful.

Research Priorities

The National Research Action Plan on Long COVID outlines research questions and topics of highest importance and with the greatest potential to yield early, safe, and effective benefit for people with Long COVID. Characterizing the Full Clinical Spectrum of Long COVID and Diagnostic Strategies, including:

  1. Pathophysiology
  2. Surveillance and Epidemiology
  3. Long COVID and Overall Well-Being
  4. Therapeutics and Other Health Interventions
  5. Human Services, Supports, and Interventions
  6. Health Services and Health Economics Research


To support the development of services, supports and interventions for Long COVID and its associated conditions data collection is important.

National surveys that provide point-in-time data of Long COVID are detailed below. Their methods, timeline, data sources, and populations vary.

Behavioral Risk Factor Surveillance System

Household Pulse Survey

Medicare Current Beneficiary Survey

National Survey of Children’s Health

National Survey on Health and Disability

National Health Interview Survey

National Health and Nutrition Examination Survey